1. Home
  2. GROY vs ABCL Comparison

GROY vs ABCL Comparison

Compare GROY & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GROY

Gold Royalty Corp.

HOLD

Current Price

$3.83

Market Cap

1.0B

Sector

N/A

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.96

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROY
ABCL
Founded
2020
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GROY
ABCL
Price
$3.83
$3.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$5.90
$8.40
AVG Volume (30 Days)
2.3M
2.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$145.80
N/A
Revenue Next Year
$60.03
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$1.43
$1.94
52 Week High
$5.45
$6.52

Technical Indicators

Market Signals
Indicator
GROY
ABCL
Relative Strength Index (RSI) 54.22 65.31
Support Level $3.25 $3.91
Resistance Level $3.83 $4.93
Average True Range (ATR) 0.17 0.17
MACD 0.06 0.06
Stochastic Oscillator 79.46 86.14

Price Performance

Historical Comparison
GROY
ABCL

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: